-
Catalogue Entry: Guidance to market authorization holders on issuing health product risk...
Guidance to market authorization holders on issuing health product risk communications: Definitions.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance on summary reports and issue-related analyses for medical devices:...
This guidance document was prepared to help medical device manufacturers understand and comply with the Medical Devices Regulations. Two new requirements in the Regulations were...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance on summary reports and issue-related analyses for medical devices: Overview
This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to 61.6 of the Medical Devices Regulations. Two new...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance on summary reports and issue-related analyses for medical devices:...
This guidance document was prepared to help medical device manufacturers understand and comply with the Medical Devices Regulations. Two new requirements in the Regulations were...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance on distinction between advertising and other activities for health...
Health Canada recognizes that it is important for industry to disseminate non-promotional, accessible information on human and animal health products to health care...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance Document - Submission of Risk Management Plan and Follow-up Commitments
The objective of this guidance document is to assist industry and interested stakeholders (Market Authorization Holders (MAHs)) in developing a Risk Management Plan and Follow-...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance Document - Health Canada and Advertising Preclearance Agencies'...
Health Canada and the Canadian Advertising Preclearance Agencies (APAs) share the common goal of maintaining integrity in health product advertising. The purpose of this... -
Catalogue Entry: Foreign risk notification for medical devices guidance document: What, when...
Information needed for a submission to comply with the Regulations, licence holders and/or importers of Class II to IV medical devices-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Foreign risk notification for medical devices guidance document:...
Medical device licence holders and importers of Class II to IV devices must notify Health Canada when there’s a serious risk of injury to human health concerning a device...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Foreign risk notification for medical devices guidance document: Monitoring,...
Requirements for manufacturers and importers for collecting medical device safety information and provide notification to Health Canada. A monitoring process should be in place...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Foreign risk notification for medical devices guidance document: Background
This guidance document is to help holders of Canadian authorizations for medical devices understand and comply with the regulatory requirements on foreign risk notification (FRN).-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Canada’s Action Plan on Medical Devices: Continuously Improving...
Despite the strong foundation of Canada’s existing Regulations, more can be done to improve the safety and effectiveness of medical devices and to optimize health outcomes for...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Guidance to market authorization holders on issuing health product risk...
In Canada, many different organizations and individuals play a role in communicating risks associated with health products.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: February 2024
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in January 2024 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: January 2024
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in December 2023 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: December 2023
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in November 2023 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: November 2023
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in October 2023 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: October 2023
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in September 2023 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Product InfoWatch: September 2023
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in August 2023 by Health Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: The advertising preclearance system
To ensure that advertising material meets Canadian regulatory standards for advertisements for drugs and medical devices, advertising preclearance agencies (APAs) provide review...-
File available for download in the following formats:
- HTML